5 research outputs found
Platelets and PEGylated lecithin liposomes: When stealth is allegedly picked up on the radar (and eaten)
PEGylation, or the chemical conjugation of polyethylene glycol (PEG) to an anchor molecule, is frequently employed in nano- and microparticle drug delivery technology to sterically stabilize the drug carrier and to confer ‘stealth’ properties. The hydrophilicity of PEGylated formulations, the repulsive interactions between PEGgrafted surfaces and blood constituents, and the decreased rate of protein adsorption on the surface of PEGylated drug carriers contribute to the evasive properties through which rapid clearance by cells of the reticuloendothelial system (RES) is considerably forestalled (Harding et al., 1997; Gabizon and Papahadjopoulos, 1992)
On the interaction of fluorophore-encapsulating PEGylated lecithin liposomes with hamster and human platelets
Polyethylene glycol (PEG)-grafted phosphatidylcholine liposomes are used as drug carriers due to their low immunogenicity and prolonged circulation time. The interaction between sterically stabilized lecithin liposomes and platelets has not been investigated before, and deserves to be subjected to scrutiny inasmuch as the uptake of liposomes by platelets could be detrimental for drug delivery and primary hemostasis. Consequently, the interaction between resting and convulxin-activated hamster and human platelets and calcein- or 5,6-carboxyfluorescein-encapsulating PEGylated liposomes composed of distearoyl- and dipalmitoyl phosphatidylcholine and PEG-derivatized distearoyl phosphatidylethanolamine was investigated by flow cytometry, confocal microscopy, and a glass capillary thrombosis model. Fluorescently labeled liposomes of the same composition were subsequently assayed in vivo after 15 and 45 min of systemic circulation. Neither resting nor activated hamster and human platelets interacted with liposomes at 0.70 mM lipid concentration. An absence of any interaction was corroborated in the in vivo experiments. Alternatively, flow cytometry assays evinced that human platelets interact with liposomes at lipid concentrations of ≥ 1.35 mM. These interactions were more profound for activated platelets than resting platelets. We conclude that the use of PEGylated lecithin liposomes at lipid concentrations of <1.35 mM has no detrimental impact on liposomal drug delivery based on PEGylated lecithin liposomes, but that these drug carriers may be associated with a reduced targeting efficacy or compromised primary hemostatic system when used at concentrations of ≥ 1.35 mM. In contrast, these drug carriers may become valuable in thrombosis- and drug delivery-related research and applications at concentrations of ≥ 1.35 mM
Biotechnology approaches to overcome biotic and abiotic stress constraints in legumes
Biotic and abiotic stresses cause significant yield losses in legumes and can significantly affect their productivity. Biotechnology tools such as marker-assisted breeding, tissue culture, in vitro mutagenesis and genetic transformation can contribute to solve or reduce some of these constraints. However, only limited success has been achieved so far. The emergence of “omic” technologies and the establishment of model legume plants such as Medicago truncatula and Lotus japonicus are promising strategies for understanding the molecular genetic basis of stress resistance, which is an important bottleneck for molecular breeding. Understanding the mechanisms that regulate the expression of stress-related genes is a fundamental issue in plant biology and will be necessary for the genetic improvement of legumes. In this review, we describe the current status of biotechnology approaches in relation to biotic and abiotic stresses in legumes and how these useful tools could be used to improve resistance to important constraints affecting legume crops.E. Prats is funded by an European Marie Curie Reintegration Grant, N. Rispail by (FP5) Eufaba
project. Our work in this area is supported by Spanish CICYT project AGL-2002-03248 and European Union project FP6-2002-FOOD-1-506223. K. Singh’s work in this area is supported in part by the Grains Research and Development Corporation (GRDC) and the Department of Education, Science and Training (DEST) in Australia.Peer reviewe